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a  b  s  t  r  a  c  t
The  establishment  and  maintenance  of  epithelial  polarity  must  be  correctly  controlled  for normal  devel-
opment  and  homeostasis.  Tight  junctions  (TJ)  in vertebrates  deﬁne  apical  and  basolateral  membrane
domains  in  polarized  epithelia  via  bi-directional,  complex  signalling  pathways  between  TJ themselves
and  the cytoskeleton  they  are  associated  with. RhoGTPases  are  central  to these  processes  and  evidence
suggests  that  their  regulation  is coordinated  by interactions  between  GEFs  and  GAPs  with  junctional,
cytoplasmic  adapter  proteins.  In this  InFocus  review  we  determine  that  the  expression,  localization  or
stability  of a variety  of  these  adaptor  proteins  is  altered  in  various  cancers,  potentially  representing  an
important  mechanistic  link  between  loss  of  polarity  and cancer.  We  focus  here,  on  two  well  character-
ized  RhoGTPases  Cdc42  and  RhoA  who’s  GEFs  and  GAPs  are  predominantly  localized  to  TJ via cytoplasmic
adaptor  proteins.
© 2015  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
Signalling network facts
• RhoGTPases are molecular switches that control TJ assembly and
function and are regulated by guanine nucleotide exchange fac-
tors (GEF) and GTPase-activating proteins (GAP) that promote a
cycling between a GTP-bound, active, and a GDP-bound, in-active
state.
• Tight junction cytoplasmic ‘plaque’ proteins, that include scaf-
fold/adaptor proteins, attach the cytoskeleton to the junctional
membrane and act as a platform for a variety of signalling pro-
teins.
• Tight junction cytoplasmic plaque adaptor proteins act as target-
ing sites for different Cdc42 and RhoA GEFs and GAPs that contain
a variety of targeting domains including (Bin Amphiphysin-Rvs)
BAR, pleckstrin homology (PH), Src Homology 3, (SH3), (PSD-
95/Dlg/ZO-1) PDZ domains to modulate correct spatio-temporal
regulation of RhoGTPases during TJ assembly and function.
• Various junctional cytoplasmic adaptor proteins are often
dysregulated in cancer by degradation, dissociation from
tight junctions, altered expression or subjected to pro-EMT
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transcriptional repression thereby, providing a potentially
important mechanistic link between loss of polarity and cancer.
1. Introduction
Epithelia provide functional barriers that separate our organs
and tissues from the external environment by forming intercellu-
lar junctions that adhere cells tightly to each other. In vertebrates
tight junctions, a component of the apical junctional complex (APC)
that also include more basally localized adherens junctions (AJ),
regulate cell-cell adhesion, paracellular permeability and main-
tain epithelial cell surface polarity by forming a discreet boarder
between apical and basolateral cell surface domains (Zihni et al.,
2014a).
Tight junctions are composed of 2 groups of proteins:
transmembrane proteins that mediate cell-cell adhesion, and cyto-
plasmic ‘plaque’ proteins that attach the cytoskeleton to the
junctional membrane and act as a platform for a variety of signalling
proteins (Zihni et al., 2014) (Fig. 1). Despite being anchored to
the cytoskeleton TJs are not static structures but dynamic and
require complex remodelling mediated by the coordinated activi-
ties of vesicle trafﬁcking machineries and the actin and microtubule
cytoskeletons, during their assembly/disassembly, function and
maintenance (Ivanov et al., 2005; Ivanov 2008; Rodgers and
Fanning, 2011).
http://dx.doi.org/10.1016/j.biocel.2015.02.020
1357-2725/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Composition of tight junctions. TJ transmembrane proteins include the tri-span BVES, the MARVEL domain-containing MARVELD3, occludin and tricellulin, the
tetraspan claudin family, Crb3 (an apical determinant that forms a complex with PALS1 and PATJ), and JAMs, CAR and angulins that are immunoglobulin superfamily
members. These transmembrane proteins interact with a cytoplasmic network of proteins, that form a ‘plaque’ that links the transmembrane proteins to the cytoskeleton.
The  cytoplasmic plaque is composed of various scaffolding proteins that contain protein–protein interaction domains and can interact directly with F-actin or microtubules
acting  as adaptors. This plaque also includes signalling proteins, such as GTPases (e.g. RhoGTPase and Raps) and their regulators that control junction assembly and function.
Another class of plaque proteins, transcriptional and post-transcriptional regulators are anchored at the TJ, but can dissociate from these structures and enter the nucleus to
regulate gene expression. Note that the proteins indicated here are major examples of TJ components, but do not represent a complete list of proteins that can be found at
TJ.  Additionally, the ﬁgure does not represent exclusivity, in other words some proteins e.g. Jacob and SH3BP1, Cdc42 and RhoA are not only restricted to TJ.
2. Functions, cascades, and key molecules
2.1. TJ adaptor protein-associated GEFs and GAPs as key
regulators of RhoA and Cdc42
RhoGTPases, members of the Ras superfamily, serve as molec-
ular switches that control TJ assembly and function. Guanine
nucleotide exchange factors (GEF) and GTPase-activating proteins
(GAP) promote a cycling of the RhoGTPase between a GTP-bound,
active state, and a GDP-bound, in-active state. In the GTP on state
they can activate downstream effector proteins, thus they are
able to transmit and convert signals from adhesion molecules,
growth factors and cytokines into biological effects to control
diverse cellular processes such as regulation of actin polymer-
ization, organization and mechanics, vesicle trafﬁcking and gene
expression, to coordinate the formation, dissolution and regula-
tion of junctions. Accumulating evidence suggest various adapter
protein constituents of the TJ cytoplasmic plaque, act as targeting
or ‘docking’ sites for GEFs and GAPs, facilitating spatio-temporal
regulation of RhoGTPases (Table 1 and Fig. 1). Junctional adap-
tor proteins not only localize GEFs and GAPs to regulate junction
assembly and function, but the status of cell-cell contact and degree
of junctional maturity and thus polarity dictates recruitment of spe-
ciﬁc GEFs and GAPs at speciﬁc times. The outline of this principle
feature of polarity was ﬁrst proposed some years ago (Drubin and
Nelson, 1996), but a great body of work since has enabled us to
begin to understand the underlying molecular principles of this
mechanism.
2.2. Spatial/temporal control of RhoGTPases during TJ assembly,
maturation and apical speciﬁcation
In many epithelia, Cdc42-driven ﬁlopodia mediated induc-
tion of cell-cell contact initiates junction assembly; although a
Rac/lamellapodia-dependent mechanism also exists depending on
the epithelial cell-type. When epithelial cells contact each other,
E-cadherin, a transmembrane protein of AJ, is recruited to sites
of cell-cell contact at the tips of ﬁlopodia by a mechanism that
is thought to involve interaction of the cytoplasmic domain of
E-cadherin with C3G, a GEF for Rap1, promoting Cdc42 acti-
vation and directional vesicle transport of E-cadherin (Takeichi
2014). Engagement of opposing E-cadherin molecules results in
the formation of a cluster, followed by the assembly of additional
adjacent puncta, generating a zipper-like structure that develops
into mature, linear cell-cell contacts. Recently, E-cadherin engage-
ment was shown to be linked to c-src-mediated phosphorylation
of cortactin, by receptor protein tyrosine phosphatase (RPTPa)
(Trufﬁ et al., 2014). Conversely, E-cadherin expression is modu-
lated in order to reduce adhesion during epithelial-mesenchymal
transition (EMT) a process that results in migration and inva-
sion during normal development and cancer (Gheldof and Berx,
2013).
The mechanism by which ﬁlopodia is converted to maturing
junctions, following nascent cell-cell contact, involves, at least in
part, the GAP SH3BP1 which forms a complex with both a junctional
adaptor protein Jacob/paracingulin and the scaffold protein CD2AP
via its N-terminal Bar domain and C-terminal SH3B domains,
respectively (Table 1 and Fig. 2b) (Elbediwy et al., 2012). Not only
does this complex attenuate actin-driven morphogenic processes
by locally inhibiting Cdc42 signalling, Capz also forms a complex
with SH3BP1, indicating a direct regulation of actin polymerization.
Recently, a mechanism for the activation of SH3BP1 GAP activity
was proposed, involving its dissociation from the PlexinD1 recep-
tor (Tata et al., 2014). SH3BP1 interacts with Plexin D1 via its BAR
domain and dissociates from this receptor following an external
stimulus involving Sema3E interaction with Plexin D1, to promote
regulation of Rac1. Whether this mechanism is associated with
activation of SH3BP1 during nascent cell-cell contacts in order
to regulate Cdc42 remains to be determined. In addition to tran-
sient inhibition of Cdc42, during nascent cell-cell contact, cadherin
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Table  1
Tight junction targeting domains of Cdc42/RhoA GEFs and GAPs.
Targeting
sequence/domain
Junctional component Function Reference(s)
GEF
Tuba C-terminal region
containing SH3 domains,
plus additional,
undetermined aa residues
TJ ZO-1 (CPAP),
Tricellulin/MARVELD2
(ITMP)
TJ conﬁguration, tension via activation
of Cdc42/N-WASP Effector, promoting
actin polymerization
Otani et al. (2006), Oda
et  al. (2014)
DBL3 N-terminal Sec 14-like
region, pleckstrin
homology (PH) domain
Ezrin (TJAMP), membrane
phospholipids?
TJ positioning via activation of
Cdc42/Par6-aPKC Effector complex
Ognibene et al. (2011),
Zihni et al. (2014b)
ECT2 N-terminal regulatory
domain (cyclin b6,
BRCT1/2, S), C-terminal
(DH, PH) region
TJ Par6 (CPAP) TJ assembly and/or maintenance via
activation of the
Cdc42/Par6-aPKC-Par3 effector
complex
Liu et al. (2004, 2006)
p114 RhoGEF N-terminal pleckstrin
homology (PH) domain,
C-terminal PDZ
(PSD-95/Dlg/ZO-1) binding
motif (PBM)
TJ Cingulin (CPAP), TJ PALS
1-associated tight junction
Protein (PATJ) (CPAP)
TJ assembly and maturation via
RhoA/ROCKII-dependent MLC
phosphorylation
Terry et al. (2011),
Nakajima and Tanoue
(2012)
ARHGEF11 C-terminal region TJ ZO-1 (CPAP) TJ assembly and maturation via
RhoA-dependent MLC phosphorylation
Itoh et al. (2012)
GEFH1 PH domain TJ Cingulin/JACOB (CPAP) Inhibition of Rho A dependent
proliferation following TJ assembly
Aijaz et al. (2005)
GAP
SH3BP1 N-terminal Bar domain
C-terminal SH3 domain
TJ Jacob (paracingulin)
(CPAP) CD2AP
TJ assembly via regulation of Cdc42 at
nascent cell-cell contacts, inactivation
of actin Polymerization and Actin
capping
Elbediwy et al. (2012)
Rich1 N-terminal Bar domain TJ angiomoitin (AMOT)
(CPAP)
TJ maturation/integrity via regulation
of Cdc42, linking TJ to intracellular
protein trafﬁcking
Wells et al. (2006)
CPAP, cytoplasmic plaque adapter protein; ITMP, integral transmembrane protein; TJAMP, tight junction apical margin protein.
engagement promotes recruitment of p190RhoGAP/ARHGAP35 to
AJ promoting RhoA inactivation (Zihni et al., 2014a). TJ formation,
induced by the junctional membrane protein BVES, then promotes
recruitment of RhoA GEF, GEF-H1 by junctional adaptors cingulin
and/or JACOB/paracingulin (Fig. 2a). The PH domain of GEF-H1
was found to interact with the rod domain of cingulin resulting
in sequestration and inhibition of GEF-H1 at TJ (Aijaz et al., 2005;
Benais-Pont et al., 2003; Guillemot et al., 2008; Russ et al., 2011).
A loss of GEF-H1 at TJ, resulting in its activation promotes RhoA-
dependent gene expression, cell cycle progression, cell spreading
and migration (Zihni et al., 2014a). Additionally, GEF-H1 dissocia-
tion and activation of RhoA/ROCKII, in a calcium depletion model,
promoted junction disassembly (Samarin et al., 2007). Studies using
non-polarized cells have shown that GEF-H1 is also sequestered by
microtubules (MT) and its activity is inhibited by phosphorylation
at Ser 885. Thrombin and lysophosphatidic acid (LPA) stimula-
tion of GPCR promotes displacement from MTs  and thrombin/PP2A
dependent de-phosphorylation resulting in its activation (Meiri
et al., 2014). It is unclear whether TJ and MT  dependent inhibitory
sequestration of GEF-H1 represent interdependent mechanisms in
polarizing cells, although a recent study suggests that cinguin links
TJs to MTs  (Yano et al., 2013).
Despite the inhibition of GEF-H1 as nascent cell-cell contacts
mature, junctional assembly and maturation further require local-
ized RhoA activation at cell-cell contacts (Fig. 2a). Firstly, the
RhoA GEF ARHGEF11 localizes initially to primordial AJ, then to
TJ, interacting with ZO-1 via its C-terminus, in polarized epithe-
lial cells to regulate the circumferential actomyosin belt (Itoh
et al., 2012), supporting a model whereby RhoA signalling at TJs is
also affected by AJs, during junction formation (McCormack et al.,
2013). A second RhoA GEF p114 RhoGEF localizes to TJs due to
interactions with cingulin and PALS1-associated tight junction pro-
tein (PATJ) via its N-terminal pleckstrin homology (PH) domain
and C-terminal PDZ (PSD-95/Dlg/ZO-1) binding motif, respectively
(Terry et al., 2011; Nakajima and Tanoue, 2012). The Ser/Thr
kinase LKB1, an important polarity factor in metazoans, activates
p114RhoGEF/RhoA, which is required for junction assembly (Xu
et al., 2013). Active P114RhoGEF forms a complex with cingulin,
MyosinIIA and RockII to regulate tension of the circumferential
actomyosin belt that is required for TJ assembly and morphogen-
esis (Terry et al., 2011). The GEF Ect2 has been shown to regulate
Cdc42 by interacting with the junctional adaptor Par6, of the Par6-
aPKC-Par3 complex, via its N-terminal and C-terminal regions, and
associate at TJs in Madin–DarbyCanineKidney (MDCK) cells (Fig. 2b)
(Zihni et al., 2014a). Binding of active Cdc42 to Par6, its effec-
tor, promotes activation of aPKC which various studies indicate,
is required for TJ formation, although Ect2 RhoGTPase speciﬁcity
may  depend on the type of epithelial cell (Zihni et al., 2014a). A sec-
ond structurally related Cdc42 GAP to SH3BP1, RICH1, is required
for junctional maturation and maintenance, which is recruited to
TJs via the junctional adaptor protein angiomotin (AMOT), via its
N-terminal BAR domain, that regulates its GAP activity (Fig. 2b)
(Wells et al., 2006). Both Rich1 and AMOT contain BAR domains
that are crescent-shaped, sensing membrane curvature, capable
of producing membrane bending and tubulation and are often
involved in the formation of vesicles. Rich1 interacts with CIN85
and CD2AP, both important proteins in endocytic regulation of
EGF and HGF receptors and knock down of Rich1 results in a loss
of integrity of junctions, and distribution of TJ components into
circular structures and fragmented spots within the cell (Wells
et al., 2006). Thus, Rich1/AMOT regulated Cdc42, at junctions may
affect TJ integrity via regulating internalization of components of
the TJ, further supporting a major role for Cdc42 in vesicle traf-
ﬁcking during epithelial polarization and TJ function (Harris and
Tepass, 2010). It is intriguing therefore, to speculate whether the
Cdc42 GAP that precedes Rich1, SH3BP1 that also contains an N-
terminal BAR domain plays a role in vesicle trafﬁcking, during TJ
assembly.
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Fig. 2. Tight junction adaptor proteins and their role in the regulation of RhoA and Cdc42. (a) (1) At low-density cells lack mature junctions and undergo proliferation. The
RhoA  activator GEF-H1 is distributed throughout the cytoplasm promoting the formation of stress ﬁbres and cell proliferation. (2) During junction maturation, GEF-H1 is
sequestered by adaptors cingulin (CNG) and JACOP/paracingulin, resulting in its inactivation and downregulation of cytoplasmic RhoA when epithelial cells reach conﬂuence
and  are no longer proliferating. Conversely, junction assembly does require restricted RhoA activity promoted by ARHGEF 11 and p114RhoGEF recruited by ZO-1 (initially at
primordial junctions) and cingulin/PATJ respectively. Recently, some activators of these GEFs have been identiﬁed for instance, LKB1 and LULU2 activates p114RhoGEF during
junction assembly (2) and apical constriction (3), respectively. (4) In various cancers junctional adaptor proteins are either * degraded by onco-viruses e.g. PATJ, ** dissociate
directly  e.g. ZO-1, or indirectly e.g. cingulin/Jacob requires ZO-1 for normal junctional localization, *** altered expression of adaptors e.g. decrease in PATJ expression leading
to  defects in TJ junction assembly or increase in GEF-H1 expression leading to pro-proliferative activity of RhoA, **** increased transcriptional activity e.g. dissociated ZO-1,
from  TJ, promotes increase transcription of CXCL/IL-8, *****EMT, e.g. ZEB1-dependent down regulation of E-cadherin and Crb3 complex including PATJ and Snail-dependent
down  regulation of Crb3 that results in decreased localization of PATJ at the tight junction. In addition to the loss of junctional adaptors Cingulin and PATJ, p114RhoGEF
function may be impaired by loss of LKB1 function. (b) (1) In many types of epithelial cells junction assembly is initiated by ﬁlopodia-mediated cell-cell contact, and E-cadherin
engagement. Local inactivation of Cdc42 by the GAP SH3BP1 that is recruited at nascent cell-cell contacts by Jacob, is required to convert ﬁlopodia to mature junctions. (2)
The  Cdc42 GEF ECT2 is suggested, at least in a cell speciﬁc manner, to be recruited by the Par complex to regulate junction assembly and a second Cdc42 GAP RICH1, is
recruited by the adapter AMOT after junction assembly to regulate Cdc42 activity, junctional maturation and integrity. Evidence suggests that RICH1 which interacts with
endocytic factors Cd2AP and CIN85 may  modulate junctional integrity via regulating vesicle trafﬁcking of TJ components. (3) The Cdc42 GEF Dbl3 also functions after junction
assembly to drive Par polarity signalling, apical expansion and brush border induction. (4) In various cancers junctional adaptor proteins either * dissociate directly e.g.
ZO-1  which evidence suggest would affect correct localization of Jacob and thus SH3BP1,**altered expression e.g. reduced expression of AMOT would result in a reduction of
sequestration of RICH1 and also the transcriptional co-activators YAP/TAZ at junctions, *** transcriptional activity e.g. nuclear translocation of YAP/TAZ promotes increased
transcription of the growth factor Cyr61, **** EMT, e.g. reduction of Crb3 expression by Snail results in loss of Par6 from junctions which has been proposed to localize in
cancer  cells to the TGF- receptor and confer a tumorigenic role.
Other GEFs and GAPs that function after junctional assembly
include the Cdc42 GEF Tuba that regulates tension and conﬁgu-
ration of junctions (Fig. 2b) (Otani et al., 2006; Oda et al., 2014).
Additionally, evidence suggest that junction assembly and matura-
tion culminates with RhoA and Cdc42 driving opposing processes
where the GEF Dbl3 drives expansion of the apical domain and
brush border induction (Fig. 2b) (Zihni et al., 2014b) and activa-
tion of p114RhGEF by Lulu2 drives RhoA dependent constriction of
the circumferential actomyosin belt, inducing apical constriction
(Fig. 2a) (Nakajima and Tanoue, 2012).
3. Associated pathologies and therapeutic
implications-focus on cancer
The development of cancer is often associated with a loss of
cohesion between epithelial cells and altered expression and/or
distribution of TJ proteins, accompanied by a loss of apicobasal
polarity (Martin, 2014; Lo et al., 2012). Changes in the expression
levels and/or localization of various TJ cytoplasmic plaque adapter
proteins have been reported in various cancers. Such a dysregu-
lation would directly affect correct recruitment of junctional GEFs
and GAPs and therefore RhoGTPase signalling, and thus disrupt TJ
assembly, maturation, and integrity (Fig. 2a and b). Furthermore,
evidence suggests that, at least, in some cases loss of junctional
cytoplasmic plaque proteins during cancer is accompanied by reg-
ulation of tumour promoting genes. For example ZO-1 which is
required for the RhoA GEF ARHGEF11 and Cdc42 GEF Tuba to local-
ize and function at TJ (Table 1 and Fig. 2a and b) relocalizes from TJs
in several breast cancer cell-lines and regulates CXCL8/IL-8 expres-
sion, a protein strongly implicated in tumour invasion (Brysse et al.,
2011). Cingulin and paracingulin, targeting sites for p114RhoGEF
and GEF-H1 RhoA GEFs and Cdc42 GAP SH3BP1, interact with ZO-
1 in vitro through their N-terminal ZIM motif and require ZO-1
for normal recruitment to TJs (Pulimeno et al., 2011). Thus, this
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Fig. 2. (Continued ).
work strongly suggests that loss of ZO-1 in cancer is likely to affect
cingulin/paracingulin localization (Fig. 2a and b).
AMOT expression, required for TJ localization of the Cdc42
GAP RICH1 (Table 1 and Fig. 2b), is deceased in lung cancer,
resulting in increased nuclear translocation of YAP/TAZ, onco-
genic transcriptional co-activators that are otherwise thought to
be sequestered/inhibited at TJ, and increased expression of the
growth factor Cyr61 (Hsu et al., 2014) (Fig. 2b). Crb3 is consid-
ered as a cancer suppressor and widely expressed in epithelial
cells (Li et al., 2015). In mouse kidney epithelial cells repression
of Crb3 expression correlates with increased tumorigenic poten-
tial. Evidence suggests that Crb3 complex components, including
PALS-1 and PAT-J (the p114RhoGEF junctional adaptor), are both
direct targets and regulators of EMT  transcriptional repressors (Li
et al., 2015). In colorectal carcinoma cells SW480 and undifferen-
tiated breast tumour cells MDA-MB-231 PATJ, in addition to Crb3
and PALS1 are up-regulated after the E-cadherin repressor ZEB1
is silenced. The transcription of Crb3 is repressed by the trans-
criptional repressor Snail thereby abolishing the localization of
the Crb complex at TJs in MDCK cells (Fig. 2a). In TGF--treated
mouse mammary epithelial Eph4 cells grown at high density,
Crb3 knockdown increases the expression of Snail and predis-
posed cells to EMT. PAT-J is also targeted for degradation by
viral oncoproteins E4-ORF, HPV-16 E6 and HPV-18 E6 (Fig. 2a)
(Lo et al., 2012). In addition to the Crb3 complex Snail also abol-
ishes TJ localization of the Par complex in MDCK cells (Fig. 2b) (Li
et al., 2015). Phosphorylation of Par6, by the TGF- receptor and
aPKC, has been correlated with reduced survival in breast cancer
patients, being associated with more invasive tumours and also
increased migration of non-small-cell lung cancer (NSCLC) cells
(Fig. 2b) (Viloria-Petita et al., 2009; Gunaratne et al., 2013). Par6 is a
junctional adaptor protein that is reported to be a target for ECT2
and activation of Cdc42-dependent Par6-aPKC/Par3 is required for
junction assembly. Thus collectively, these studies indicate that a
loss of junctional localization of this adaptor promotes a switch
from a Cdc42-dependent pro junction assembly role to a tumori-
genic role via relocalization to a distinct functional membrane
complex (Fig. 2b). In addition to a potential loss of inhibitory
sequestration of GEFH1 at TJ, increased expression of human pitu-
itary tumour-transforming gene 1 (hPTTG1), a transcription factor
overexpressed in many types of tumour, transcriptionally activates
GEFH1 expression in a highly metastatic breast cancer cell-line
(Liao et al., 2012) which may  overcome the inhibitory capacity of
TJ-bound cingulin (Fig. 2a).
4. Concluding remarks
As we continue to understand the structure and molecular
mechanisms of TJ regulation, it is becoming clear that this com-
plex structure and associated signalling modules, is potentially an
important therapeutic target for anticancer research. Presently, a
focus on drugs being developed, include those that manipulate
the permeability regulation properties of transmembrane claudins
to interfere with the path of tumour metastasis (Martin, 2014).
Understanding further the mechanism and functions of other TJ
molecules including cytoplasmic plaque protein adaptor molecules
and interdependent RhoGTPase signalling networks, as highlighted
in this review, will enable further possibilities to utilize/manipulate
these TJ components and related-signalling networks as targets
or strategies for cancer therapy during earlier stages of cancer
development. Such an example may  be illustrated by the recent dis-
covery of LKB1, inactivated in a variety of cancers, as an activator of
C. Zihni, S.J. Terry / The International Journal of Biochemistry & Cell Biology 64 (2015) 120–125 125
p114RhoGEF-driven junction assembly, which occurs via recruit-
ment by cingulin and PATJ junctional adaptors. LKB1 possess a
unique feature as a tumour suppressor by promoting cell survival
via suppressing cell proliferation under energetic stress conditions
(Zhou et al., 2014). Thus, Since, LKB1-null cells ability to sense
energetic stress is impaired and are therefore more vulnerable, the
potential to utilize drugs such as phenformin in order to kill cells
when LKB1 function is absent, has arisen.
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